Anti-SLAMF7 Recombinant Antibody (Elotuzumab) (CAT#: TAB-743)

Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. Elotuzumab is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG1 – kappa
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, IHC and most other immunological methods.
  • CAS
  • 915296-00-3
  • Generic Name
  • elotuzumab
  • UNII
  • 1351PE5UGS
  • MW
  • 145.5 kDa
  • Related Disease
  • Multiple myeloma (MM)
This site uses cookies. Find out more about this site’s cookies. GOT IT!